23
Participants
Start Date
June 30, 2007
Primary Completion Date
September 30, 2010
Study Completion Date
December 31, 2011
infliximab
Infliximab 5 mg/kg. i.v. at week 0, 2, 6, 14 y 22.
inactive powder
Inactive powder. i.v. at week 0, 2, 6, 14 y 22.
Reumatology division, Hospital Universitario Marques de Valdecilla, Santander
Collaborators (1)
Schering-Plough
INDUSTRY
Hospital Universitario Marqués de Valdecilla
OTHER